Top leaders at FDA marketing overseer resign, potentially teeing up RFK Jr.’s promised drug ad ban: report
OPDP director Catherine Gray and deputy director Mark Askine told staffers on Thursday that they were leaving, and their resignations took effect Friday, Politico’s AgencyIQ reports, citing emails shared by sources within the office.
